Haas Jason

EDGAR CIK 0001883821

Syros Pharmaceuticals, Inc. - SYRS

CFO
Chief Financial Officer
Direct Buys
3
$161,240
100,000 Shares
Direct Sells
1
($28,980)
-137,803 Shares
Indirect Buys
0
$0
0 Shares
Indirect Sells
0
$0
0 Shares
Monthly Values

Transaction Filed Type Shares @ Price Value Balance ( Change % ) Ownership
11/18/2024
11/20/2024
Sell
-137,803 @ $0.21
($28,980) 0 (-100.00%) Direct
09/12/2024
09/12/2024
Buy
45,344 @ $1.68
$76,006 124,552 (57.25%) Direct
09/11/2024
09/12/2024
Buy
19,293 @ $1.58
$30,446 79,208 (32.20%) Direct
09/10/2024
09/12/2024
Buy
35,363 @ $1.55
$54,788 59,915 (144.03%) Direct